About Intellectual Property IP Training IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars World IP Day WIPO Magazine Raising Awareness Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Enforcement Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO ALERT Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight

IP Outreach Research > IP Crime

Reference

Title: Greater Expectations: Pharmacy Based Health Care - The Future for Europe?
Author: Sara Garfield, Jean Hawkins, Jennifer Newbould, Timothy Rennie and David Taylor [The School of Pharmacy, University of London], [ICM Research]
Source:

http://www.pharmacy.ac.uk/fileadmin/documents/News/Greater_Expectations_web_edition.pdf
Year: 2007

Details

Subject/Type: Counterfeiting
Focus: Medicines and Medical Devices
Country/Territory: France, Germany, Greece, Poland, Sweden, United Kingdom
Objective: To provide an up-to-date insight into European public beliefs about the potential of community pharmacists to act as medicines prescribers.
Sample: 1.000+ adults in France, Germany, Greece, Poland, Sweden, and the United Kingdom
Methodology: Telephone interviews (France, Germany, Greece, Sweden, United Kingdom), face-to-face interviews (Poland)

Main Findings

Overall, 74% of the European public interviewed agreed that there is a growing risk from counterfeit medicines. Agreement with this statement was highest in Germany (with 86% either agreeing or strongly agreeing), followed by Sweden (83%), Greece (82%) and Poland (72%).

In France and the United Kingdom, 61% and 55% respectively felt that there is a growing counterfeit medicines risk.

[Date Added: Mar 31, 2009 ]

https://www3.wipo.int/contact/en/area.jsp?area=communications https://www.wipo.int/pressroom/en/ https://www.wipo.int/tools/en/disclaim.html https://www.wipo.int/en/web/privacy-policy/ https://www.wipo.int/en/web/accessibility/ https://www.wipo.int/tools/en/sitemap.html https://www3.wipo.int/newsletters/en/ https://www.wipo.int/podcasts/en/ https://www.wipo.int/news/en/